[HTML][HTML] Analysis of the prognostic factors of simultaneous integrated boost-intensity modulated radiation therapy (SIB-IMRT) in 220 cases of locally advanced …
S Zhou, Y Yang, Q Zhang, C Zhu, P Cai… - Annals of Translational …, 2023 - ncbi.nlm.nih.gov
Background Esophageal cancer is one of the most common malignant tumors in China.
Patients with advanced esophageal cancer often cannot be treated by surgery; in these …
Patients with advanced esophageal cancer often cannot be treated by surgery; in these …
Analysis of the prognostic factors of simultaneous integrated boost-intensity modulated radiation therapy (SIB-IMRT) in 220 cases of locally advanced squamous …
S Zhou, Y Yang, Q Zhang, C Zhu… - Annals of …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Esophageal cancer is one of the most common malignant tumors in China.
Patients with advanced esophageal cancer often cannot be treated by surgery; in these …
Patients with advanced esophageal cancer often cannot be treated by surgery; in these …
Analysis of the prognostic factors of simultaneous integrated boost-intensity modulated radiation therapy (SIB-IMRT) in 220 cases of locally advanced squamous …
S Zhou, Y Yang, Q Zhang, C Zhu, P Cai… - Annals of Translational …, 2023 - europepmc.org
Background Esophageal cancer is one of the most common malignant tumors in China.
Patients with advanced esophageal cancer often cannot be treated by surgery; in these …
Patients with advanced esophageal cancer often cannot be treated by surgery; in these …
[PDF][PDF] Analysis of the prognostic factors of simultaneous integrated boost-intensity modulated radiation therapy (SIB-IMRT) in 220 cases of locally advanced …
S Zhou, Y Yang, Q Zhang, C Zhu, P Cai, D Li - 2023 - cdn.amegroups.cn
Background: Esophageal cancer is one of the most common malignant tumors in China.
Patients with advanced esophageal cancer often cannot be treated by surgery; in these …
Patients with advanced esophageal cancer often cannot be treated by surgery; in these …
[HTML][HTML] Analysis of the prognostic factors of simultaneous integrated boost-intensity modulated radiation therapy (SIB-IMRT) in 220 cases of locally advanced …
S Zhou, Y Yang, Q Zhang, C Zhu… - Annals of Translational …, 2023 - atm.amegroups.org
Background: Esophageal cancer is one of the most common malignant tumors in China.
Patients with advanced esophageal cancer often cannot be treated by surgery; in these …
Patients with advanced esophageal cancer often cannot be treated by surgery; in these …
Analysis of the prognostic factors of simultaneous integrated boost-intensity modulated radiation therapy (SIB-IMRT) in 220 cases of locally advanced squamous …
S Zhou, Y Yang, Q Zhang, C Zhu, P Cai… - Annals of Translational …, 2023 - europepmc.org
Background Esophageal cancer is one of the most common malignant tumors in China.
Patients with advanced esophageal cancer often cannot be treated by surgery; in these …
Patients with advanced esophageal cancer often cannot be treated by surgery; in these …
[引用][C] Analysis of the prognostic factors of simultaneous integrated boost-intensity modulated radiation therapy (SIB-IMRT) in 220 cases of locally advanced …
S Zhou, Y Yang, Q Zhang, C Zhu… - Annals of Translational …, 2023 - atm.amegroups.org
Analysis of the prognostic factors of simultaneous integrated boost-intensity modulated
radiation therapy (SIB-IMRT) in 220 cases of locally advanced squamous esophageal …
radiation therapy (SIB-IMRT) in 220 cases of locally advanced squamous esophageal …